Pages
Products
AAV2-CAG-FLuc-2A-GFP

AAV2-CAG-FLuc-2A-GFP

Cat.No. :  AAV00497Z

Titer: ≥1x10^12 GC/mL / ≥1x10^13 GC/mL Size: 30 ul/100 ul/500 ul/1 ml

Serotype:  AAV Serotype 2 Storage:  -80 ℃

Inquire for Price

AAV Particle Information

Quality Control

Cat. No. AAV00497Z
Description AAV serotype 2 particles express 2A-linked firefly luciferase (FLuc) reporter gene and GFP reporter gene under the control of CAG promoter.
Reporter GFP, FLuc
Serotype AAV Serotype 2
Target Gene FLuc-2A-GFP
Application

1. Determination of optimal MOI (multiplicity of infection), administration methods etc.

2. Detection of the infection efficiency of the AAV serotype against a specific cell type or tissue.

3. Using reporter genes to visualize the distribution and expression of AAV vectors in live animals, helping assess the biodistribution and persistence of gene delivery.

Titer Varies lot by lot, typically ≥1x10^12 GC/mL
Size Varies lot by lot, for example, 30 μL, 50 μL, 100 μL etc.
Storage Store at -80℃. Avoid multiple freeze/thaw cycles.
Shipping Frozen on dry ice
Creative Biogene ensures high-quality AAV particles by optimizing and standardizing production protocols and performing stringent quality control (QC). The specific QC experiments performed vary between AAV particle lots.
Endotoxin Endotoxins, primarily derived from Gram-negative bacteria, can trigger adverse immune responses. Endotoxin contamination is a significant concern in the production of AAV, especially for applications in animal studies and gene therapy. Effective endotoxin quality control is essential in the development and manufacturing of AAV particles. Creative Biogene utilizes rigorous endotoxin detection methods to monitor the endotoxin level in our produced AAV particles to ensure regulatory compliance.
Purity AAV purity is critical for ensuring the safety and efficacy of AAV-based applications.AAV capsids are composed of three main protein components, known as viral proteins: VP1, VP2, and VP3. These proteins play a critical role in the structure and functionality of the AAV capsid. Monitoring the VP1, VP2, and VP3 content in AAV preparations is essential for quality control in AAV production. Our AAV particles are tested for showing three clear bands of VP1, VP2 VP3 by SDS-PAGE.
Sterility The AAV virus samples are inoculated into the cell culture medium for about 5 days to detect bacterial and fungal growth.
Transducibility Upon requirement, Creative Biogene can perform in vitro or in vivo transduction assays to evaluate the ability of AAV to deliver genetic material into target cells or tissues, and assess gene expression and functional activities.
Empty vs. Full Capsids Based-on our proprietary AAV production and purification technology, Creative Biogene can always offer AAV particles with high ratio of full capsids. If required, we can also assess the ratio for a specifc lot of AAV particles by transmission electron microscopy (TEM) or other methods.
Quick Inquiry

Background

Publications

Q & A

Customer Reviews

rAAV is a popular viral vector system in clinical trials. The vast majority of past and current clinical trials employ AAV vectors based on serotype 2. Most of these applications focus on the treatment of monogenic disorders such as cystic fibrosis, Duchenne muscular dystrophy, alpha-1-antitrypsin deficiency and haemophilia B, and cancer using local vector application or rAAV modified cells, respectively. In addition, rAAV-2 is routinely used as a gene transfer vector for in vitro transduction and in a large number of pre-clinical animal models. In vivo AAV serotypes other than rAAV-2 have demonstrated superior transduction efficiencies for a variety of tissues. For example, rAAV-1 is reported to be more effective than rAAV-2 in transducing muscle, arthritic joints, pancreatic islets, heart, vascular endothelium, central nervous system (CNS), and hepatocytes, whereas rAAV-3 appears well suited for transducing cochlear inner hair cells, AAV-4 for transducing the brain, AAV-5 for transducing the CNS, lung, eye, arthritic joints, and hepatocytes, rAAV-6 for transducing muscle, heart, and airway epithelium, rAAV-7 for transducing muscle, and rAAV-8 for transducing muscle, pancreas, heart, and liver.
Ask a Question

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

Customer Reviews
Reliable Delivery

The AAV2-CAG-FLuc-2A-GFP was shipped promptly and came with comprehensive instructions, making the whole process straightforward and user-friendly for our lab team.

Canada

11/16/2020

Write a Review

Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.

Needs improvement

Satisfaction

General satisfaction

Very satisfaction